Status:
COMPLETED
Optiflow® to Prevent Post-Extubation Hypoxemia afteR Abdominal Surgery (the OPERA Trial)
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Postoperative Hypoxemia
Eligibility:
All Genders
19+ years
Phase:
PHASE4
Brief Summary
To evaluate whether early application of nasal high flow oxygen therapy after extubation can reduce the incidence of postoperative hypoxemia (defined as a PaO2/FiO2 ratio \<300) after abdominal surger...
Detailed Description
Postoperative hypoxemia complicates between 30 to 50% of patients after abdominal surgery. Loss of functioning alveolar units and development of atelectasis after abdominal surgery have been recognize...
Eligibility Criteria
Inclusion
- Planned or unplanned surgical procedures
- Abdominal or abdominal and thoracic surgery
- Expected duration ≥2 hours
- ARISCAT score ≥26 points
Exclusion
- Age \<18 years
- Body mass index \>35 kg/m2
- Sleep apnea syndrome
- Patient refusal
- Pregnancy and/or lactation
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT01887015
Start Date
June 1 2013
End Date
March 1 2015
Last Update
March 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003